Study of Andes virus entry and neutralization using a pseudovirion system

Journal of Virological Methods

Volumn 163, Issue 2, 2010, Pages 416-423

  Ray, Neelanjana ^a   Whidby, Jillian ^a   Stewart, Shaun ^a   Hooper, Jay W ^b   Bertolotti Ciarlet, Andrea ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNITED STATES ARMY MEDICAL RESEARCH INSTITUTE OF INFECTIOUS DISEASES   (United States)

Author keywords

Andes virus; Cell entry; Neutralization; Pseudovirion

Indexed keywords

BETA3 INTEGRIN; CELL SURFACE PROTEIN; GLYCOPROTEIN; GLYCOPROTEIN N; MATRIX PROTEIN; PROTEIN C; RENILLA LUCIFERIN 2 MONOOXYGENASE; UNCLASSIFIED DRUG;

ANDES VIRUS; ANIMAL CELL; ARTICLE; ASSAY; BIOSAFETY; CELL LYSATE; CONTROLLED STUDY; DEFECTIVE VIRUS; EMBRYO; ENZYME ACTIVITY; FEMALE; FETUS; HANTAVIRUS; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; PSEUDOVIRION ASSAY; SENSITIVITY AND SPECIFICITY; VESICULAR STOMATITIS VIRUS; VIRION; VIRUS CELL INTERACTION; VIRUS CORE; VIRUS ENTRY; VIRUS GENE; VIRUS INFECTION; VIRUS INFECTIVITY; VIRUS NEUTRALIZATION; VIRUS REPLICATION;

ANIMALS; ANTIBODIES, NEUTRALIZING; ANTIBODIES, VIRAL; CELL LINE; CERCOPITHECUS AETHIOPS; CRICETINAE; GENES, REPORTER; GENETIC VECTORS; HANTAVIRUS; HUMANS; LUCIFERASES, RENILLA; MEMBRANE GLYCOPROTEINS; NEUTRALIZATION TESTS; PLAQUE ASSAY; RABBITS; STATISTICS AS TOPIC; VESICULOVIRUS; VIRAL STRUCTURAL PROTEINS; VIROLOGY; VIRUS INTERNALIZATION;

ANDES VIRUS; BUNYAVIRIDAE; CRICETINAE; HANTAVIRUS; RENILLA LUCIFERASE; VESICULAR STOMATITIS VIRUS;

EID: 73049107691     PISSN: 01660934     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jviromet.2009.11.004     Document Type: Article

References (45)

1. Aguilar H.C., Matreyek K.A., Filone C.M., Hashimi S.T., Levroney E.L., Negrete O.A., Bertolotti-Ciarlet A., Choi D.Y., McHardy I., Fulcher J.A., Su S.V., Wolf M.C., Kohatsu L., Baum L.G., and Lee B. N-glycans on Nipah virus fusion protein protect against neutralization but reduce membrane fusion and viral entry. J. Virol. 80 (2006) 4878-4889
2. Arikawa J., Takashima I., Hashimoto N., Morita C., Sugiyama K., Matsuura Y., Shiga S., and Kitamura T. Epidemiological study of hemorrhagic fever with renal syndrome related virus infection among urban rats in two islands in Tokyo Bay, Japan. Acta Virol. 29 (1985) 66-72
3. Banerjee M., and Johnson J.E. Activation, exposure and penetration of virally encoded, membrane-active polypeptides during non-enveloped virus entry. Curr. Protein Pept. Sci. 9 (2008) 16-27
4. Blystone S.D., Lindberg F.P., Williams M.P., McHugh K.P., and Brown E.J. Inducible tyrosine phosphorylation of the beta3 integrin requires the alphaV integrin cytoplasmic tail. J. Biol. Chem. 271 (1996) 31458-31462
5. Brown J.C., Newcomb W.W., and Lawrenz-Smith S. pH-dependent accumulation of the vesicular stomatitis virus glycoprotein at the ends of intact virions. Virology 167 (1988) 625-629
6. Burton D.R., Williamson R.A., and Parren P.W. Antibody and virus: binding and neutralization. Virology 270 (2000) 1-3
7. Custer D.M., Thompson E., Schmaljohn C.S., Ksiazek T.G., and Hooper J.W. Active and passive vaccination against hantavirus pulmonary syndrome with Andes virus M genome segment-based DNA vaccine. J. Virol. 77 (2003) 9894-9905
8. Douglass R.J., Calisher C.H., Wagoner K.D., and Mills J.N. Sin Nombre virus infection of deer mice in Montana: characteristics of newly infected mice, incidence, and temporal pattern of infection. J. Wildl. Dis. 43 (2007) 12-22
9. Enria D., Padula P., Segura E.L., Pini N., Edelstein A., Posse C.R., and Weissenbacher M.C. Hantavirus pulmonary syndrome in Argentina. Possibility of person to person transmission. Medicina (B Aires) 56 (1996) 709-711
10. Ferres M., Vial P., Marco C., Yanez L., Godoy P., Castillo C., Hjelle B., Delgado I., Lee S.J., and Mertz G.J. Prospective evaluation of household contacts of persons with hantavirus cardiopulmonary syndrome in chile. J. Infect. Dis. 195 (2007) 1563-1571
11. Galeno H., Mora J., Villagra E., Fernandez J., Hernandez J., Mertz G.J., and Ramirez E. First human isolate of Hantavirus (Andes virus) in the Americas. Emerg. Infect. Dis. 8 (2002) 657-661
12. Gavrilovskaya I.N., Brown E.J., Ginsberg M.H., and Mackow E.R. Cellular entry of hantaviruses which cause hemorrhagic fever with renal syndrome is mediated by beta3 integrins. J. Virol. 73 (1999) 3951-3959
13. Gavrilovskaya I.N., Peresleni T., Geimonen E., and Mackow E.R. Pathogenic hantaviruses selectively inhibit beta3 integrin directed endothelial cell migration. Arch. Virol. 147 (2002) 1913-1931
14. Gavrilovskaya I.N., Shepley M., Shaw R., Ginsberg M.H., and Mackow E.R. beta3 Integrins mediate the cellular entry of hantaviruses that cause respiratory failure. Proc. Natl. Acad. Sci. USA 95 (1998) 7074-7079
15. Glass G.E., Cheek J.E., Patz J.A., Shields T.M., Doyle T.J., Thoroughman D.A., Hunt D.K., Enscore R.E., Gage K.L., Irland C., Peters C.J., and Bryan R. Using remotely sensed data to identify areas at risk for hantavirus pulmonary syndrome. Emerg. Infect. Dis. 6 (2000) 238-247
16. Hjelle B., Goade D., Torrez-Martinez N., Lang-Williams M., Kim J., Harris R.L., and Rawlings J.A. Hantavirus pulmonary syndrome, renal insufficiency, and myositis associated with infection by Bayou hantavirus. Clin. Infect. Dis. 23 (1996) 495-500
17. Hooper J.W., Custer D.M., Thompson E., and Schmaljohn C.S. DNA vaccination with the Hantaan virus M gene protects Hamsters against three of four HFRS hantaviruses and elicits a high-titer neutralizing antibody response in Rhesus monkeys. J. Virol. 75 (2001) 8469-8477
18. Khaiboullina S.F., Morzunov S.P., and St Jeor S.C. Hantaviruses: molecular biology, evolution and pathogenesis. Curr. Mol. Med. 5 (2005) 773-790
19. Klasse P.J., and Sattentau Q.J. Mechanisms of virus neutralization by antibody. Curr. Top. Microbiol. Immunol. 260 (2001) 87-108
20. Klein S.L., Bird B.H., and Glass G.E. Sex differences in immune responses and viral shedding following Seoul virus infection in Norway rats. Am. J. Trop. Med. Hyg. 65 (2001) 57-63
21. Lamb R.A., and Jardetzky T.S. Structural basis of viral invasion: lessons from paramyxovirus F. Curr. Opin. Struct. Biol. 17 (2007) 427-436
22. Lee B.H., Yoshimatsu K., Araki K., Okumura M., Nakamura I., and Arikawa J. A pseudotype vesicular stomatitis virus containing Hantaan virus envelope glycoproteins G1 and G2 as an alternative to hantavirus vaccine in mice. Vaccine 24 (2006) 2928-2934
23. Lee H.W., and van der Groen G. Hemorrhagic fever with renal syndrome. Prog. Med. Virol. 36 (1989) 62-102
24. Levis S., Rowe J.E., Morzunov S., Enria D.A., and St Jeor S. New hantaviruses causing hantavirus pulmonary syndrome in central Argentina. Lancet 349 (1997) 998-999
25. Lopez N., Padula P., Rossi C., Lazaro M.E., and Franze-Fernandez M.T. Genetic identification of a new hantavirus causing severe pulmonary syndrome in Argentina. Virology 220 (1996) 223-226
26. Martinez V.P., Bellomo C., San Juan J., Pinna D., Forlenza R., Elder M., and Padula P.J. Person-to-person transmission of Andes virus. Emerg. Infect. Dis. 11 (2005) 1848-1853
27. McCaughey C., Shi X., Elliot R.M., Wyatt D.E., O'Neill H.J., and Coyle P.V. Low pH-induced cytopathic effect-a survey of seven hantavirus strains. J. Virol. Methods 81 (1999) 193-197
28. McElroy A.K., Smith J.M., Hooper J.W., and Schmaljohn C.S. Andes virus M genome segment is not sufficient to confer the virulence associated with Andes virus in Syrian hamsters. Virology 326 (2004) 130-139
29. Mou D.L., Wang Y.P., Huang C.X., Li G.Y., Pan L., Yang W.S., and Bai X.F. Cellular entry of Hantaan virus A9 strain: specific interactions with beta3 integrins and a novel 70 kDa protein. Biochem. Biophys. Res. Commun. 339 (2006) 611-617
30. Negrete O.A., Levroney E.L., Aguilar H.C., Bertolotti-Ciarlet A., Nazarian R., Tajyar S., and Lee B. EphrinB2 is the entry receptor for Nipah virus, an emergent deadly paramyxovirus. Nature 436 (2005) 401-405
31. Ogino M., Ebihara H., Lee B.H., Araki K., Lundkvist A., Kawaoka Y., Yoshimatsu K., and Arikawa J. Use of vesicular stomatitis virus pseudotypes bearing hantaan or seoul virus envelope proteins in a rapid and safe neutralization test. Clin. Diagn. Lab. Immunol. 10 (2003) 154-160
32. Okuno Y., Yamanishi K., Takahashi Y., Tanishita O., Nagai T., Dantas Jr. J.R., Okamoto Y., Tadano M., and Takahashi M. Haemagglutination-inhibition test for haemorrhagic fever with renal syndrome using virus antigen prepared from infected tissue culture fluid. J. Gen. Virol. 67 (1986) 149-156
33. Padula P.J., Edelstein A., Miguel S.D., Lopez N.M., Rossi C.M., and Rabinovich R.D. Hantavirus pulmonary syndrome outbreak in Argentina: molecular evidence for person-to-person transmission of Andes virus. Virology 241 (1998) 323-330
34. Pinna D.M., Martinez V.P., Bellomo C.M., Lopez C., and Padula P. New epidemiologic and molecular evidence of person to person transmission of hantavirus Andes Sout. Medicina (B Aires) 64 (2004) 43-46
35. Plyusnin A., and Morzunov S.P. Virus evolution and genetic diversity of hantaviruses and their rodent hosts. Curr. Top. Microbiol. Immunol. 256 (2001) 47-75
36. Puri A., Winick J., Lowy R.J., Covell D., Eidelman O., Walter A., and Blumenthal R. Activation of vesicular stomatitis virus fusion with cells by pretreatment at low pH. J. Biol. Chem. 263 (1988) 4749-4753
37. Rowe R.K., and Pekosz A. Bidirectional virus secretion and nonciliated cell tropism following Andes virus infection of primary airway epithelial cell cultures. J. Virol. 80 (2006) 1087-1097
38. Schmaljohn C.S., Hasty S.E., Harrison S.A., and Dalrymple J.M. Characterization of Hantaan virions, the prototype virus of hemorrhagic fever with renal syndrome. J. Infect. Dis. 148 (1983) 1005-1012
39. Schmaljohn C.S., Schmaljohn A.L., and Dalrymple J.M. Hantaan virus M RNA: coding strategy, nucleotide sequence, and gene order. Virology 157 (1987) 31-39
40. Tischler N.D., Gonzalez A., Perez-Acle T., Rosemblatt M., and Valenzuela P.D. Hantavirus Gc glycoprotein: evidence for a class II fusion protein. J. Gen. Virol. 86 (2005) 2937-2947
41. Valdivieso F., Vial P., Ferres M., Ye C., Goade D., Cuiza A., and Hjelle B. Neutralizing antibodies in survivors of Sin Nombre and Andes hantavirus infection. Emerg. Infect. Dis. 12 (2006) 166-168
42. Xu Z., Wei L., Wang L., Wang H., and Jiang S. The in vitro and in vivo protective activity of monoclonal antibodies directed against Hantaan virus: potential application for immunotherapy and passive immunization. Biochem. Biophys. Res. Commun. 298 (2002) 552-558
43. Yanagihara R., Daum C.A., Lee P.W., Baek L.J., Amyx H.L., Gajdusek D.C., and Gibbs Jr. C.J. Serological survey of Prospect Hill virus infection in indigenous wild rodents in the USA. Trans. R. Soc. Trop. Med. Hyg. 81 (1987) 42-45
44. Zaki S.R., Greer P.W., Coffield L.M., Goldsmith C.S., Nolte K.B., Foucar K., Feddersen R.M., Zumwalt R.E., Miller G.L., Khan A.S., Rollin P.E., Ksiazek T.G., Nichol S.T., Mahy B.W.J., and Peters C.J. Hantavirus pulmonary syndrome. Pathogenesis of an emerging infectious disease. Am. J. Pathol. 146 (1995) 552-579
45. Zheng F., Ma L., Shao L., Wang G., Chen F., Zhang Y., and Yang S. Envelope glycoproteins of hantavirus can mediate cell-cell fusion independently. New Microbiol. 30 (2007) 101-107